Coming of age: molecular drivers of aging and therapeutic opportunities
Open Access
- 1 March 2013
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 123 (3), 946-950
- https://doi.org/10.1172/jci68833
Abstract
Aging is like the weather: everyone talks about it, but no one seems to do anything about it. We believe this may soon change, as an improved understanding of the molecular and genetic pathways underlying aging suggests it is possible to therapeutically target the aging process and increase health span. This Review series focuses on fundamental cellular mechanisms of aging and their relationship to human disease. These pathways include telomere dysfunction in cellular senescence and induction of the senescence-associated secretory phenotype (SASP) in systemic aging, sirtuin family regulation of metabolism and aging-associated diseases, mitochondrial metabolism in aging, the mechanistic target of rapamycin (mTOR) signaling pathway and the use of mTOR inhibitors to increase longevity, the progressive decline of the immune system with age, and aging-associated changes to pancreatic islet β cells that may contribute to diabetes. Together, these articles explore pathways affecting aging and possible interventional targets to slow or delay the onset of age-related pathologies.Keywords
This publication has 29 references indexed in Scilit:
- Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index CategoriesJama-Journal Of The American Medical Association, 2013
- The Longevity of SirtuinsCell Reports, 2012
- Impact of caloric restriction on health and survival in rhesus monkeys from the NIA studyNature, 2012
- The redox stress hypothesis of agingFree Radical Biology & Medicine, 2012
- PDGF signalling controls age-dependent proliferation in pancreatic β-cellsNature, 2011
- Absence of effects of Sir2 overexpression on lifespan in C. elegans and DrosophilaNature, 2011
- Comparison of exendin-4 on beta-cell replication in mouse and human islet graftsTransplant International, 2011
- SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1Journal of Biological Chemistry, 2010
- Is the oxidative stress theory of aging dead?Biochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Resveratrol is Not a Direct Activator of SIRT1 Enzyme ActivityChemical Biology & Drug Design, 2009